Does Race Affect Postoperative Outcomes in Patients With Low-Risk Prostate Cancer Who Undergo Radical Prostatectomy?
Matthew J. Resnick(Vanderbilt University Medical Center), S. Bruce Malkowicz(University of Pennsylvania), Meredith Bergey(Brandeis University), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Benjamin M. Brucker(University of Pennsylvania), Seema S. Sonnad(University of Pennsylvania), Alan J. Wein(University of Miami), Daniel Canter(Ochsner Medical Center)
Cited by 41
Related Papers
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
|The Journal of Urology|2020|268